Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism
Cholesteryl ester transfer protein (CETP) inhibition leads to changes in lipoprotein metabolism. We studied the effect of the CETP inhibitor torcetrapib on VLDL apolipoprotein E (apoE) metabolism. Subjects, pretreated with atorvastatin (n = 9) or untreated (n = 10), received placebo followed by torc...
Main Authors: | John S. Millar, Margaret E. Brousseau, Margaret R. Diffenderfer, P. Hugh R. Barrett, Francine K. Welty, Jeffrey S. Cohn, Aisha Wilson, Megan L. Wolfe, Chorthip Nartsupha, Peter M. Schaefer, Andres G. Digenio, James P. Mancuso, Gregory G. Dolnikowski, Ernst J. Schaefer, Daniel J. Rader |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2008-03-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520424125 |
Similar Items
-
Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism
by: Margaret E. Brousseau, et al.
Published: (2009-07-01) -
The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor
by: Jose Ruiz, et al.
Published: (2005-08-01) -
Measuring VLDL-triglyceride turnover in humans using ex vivo-prepared VLDL tracer
by: Lars C. Gormsen, et al.
Published: (2006-01-01) -
Apolipoprotein A-I, A-II, and VLDL-B-100 metabolism in men
by: Sophie Desroches, et al.
Published: (2004-12-01) -
Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency
by: Bela F. Asztalos, et al.
Published: (2004-03-01)